Zhaoyan's new drug: Net profit of 298 million yuan in 2025, a year-on-year increase of 302.08%

Sina Finance reported on March 30th that Zhaoyan Pharmaceuticals announced that in 2025, its operating income reached 1.658 billion yuan, a year-on-year decrease of 17.87%; net profit was 298 million yuan, a year-on-year increase of 302.08%. It plans to distribute a cash dividend of 1.2 yuan per 10 shares to all shareholders.